Effect of propranolol on HDL cholesterol concentrations.
作者信息
Streja D, Mymin D
出版信息
Br Med J. 1978 Nov 25;2(6150):1495. doi: 10.1136/bmj.2.6150.1495-b.
Abstract
摘要
相似文献
1
Effect of propranolol on HDL cholesterol concentrations.普萘洛尔对高密度脂蛋白胆固醇浓度的影响。
Br Med J. 1978 Nov 25;2(6150):1495. doi: 10.1136/bmj.2.6150.1495-b.
2
Beta blockers, lipids, and coronary atherosclerosis.β受体阻滞剂、血脂与冠状动脉粥样硬化
Br Med J (Clin Res Ed). 1988 Apr 30;296(6631):1257-8. doi: 10.1136/bmj.296.6631.1257-a.
3
[Drug lowering of the HDL concentration in the serum of cardiologically treated patients].[药物降低经心脏科治疗患者血清中高密度脂蛋白浓度的研究]
Z Gesamte Inn Med. 1982 Oct 1;37(19):654-8.
4
[HDL-cholesterol in coronary disease in the acute phase].[急性冠脉疾病中的高密度脂蛋白胆固醇]
Boll Soc Ital Cardiol. 1981;26(11):1823-5.
5
[Cholesterol in serum lipoprotein fractions in patients with hyperthyroidism treated with propranolol].[用普萘洛尔治疗的甲状腺功能亢进患者血清脂蛋白组分中的胆固醇]
Pol Arch Med Wewn. 1983 Oct;70(4):149-59.
6
[Behavior of HDL cholesterol in normal subjects and coronary disease patients: preliminary observations].[正常受试者和冠心病患者中高密度脂蛋白胆固醇的行为：初步观察]
Boll Soc Ital Cardiol. 1980;25(3):301-4.
7
[HDL-cholesterol and coronary atherosclerosis].[高密度脂蛋白胆固醇与冠状动脉粥样硬化]
Arq Bras Cardiol. 1980 Jun;34(6):485-91.
8
Serum HDL-cholesterol, apo-A-I and apo-E levels in patients with abnormal coronary arteries.冠状动脉异常患者的血清高密度脂蛋白胆固醇、载脂蛋白A-I和载脂蛋白E水平。
Clin Invest Med. 1980;3(3-4):225-32.
9
[HDL cholesterol and coronary risk (author's transl)].
Ann Cardiol Angeiol (Paris). 1980 Oct-Nov;29(6):431-7.
10
[Initial results of HDL-cholesterol follow-up in patients with ischemic cerebrovascular disease and multiple sclerosis (significance of the ratio between HDL-cholesterol and total cholesterol)].[缺血性脑血管疾病和多发性硬化症患者高密度脂蛋白胆固醇随访的初步结果（高密度脂蛋白胆固醇与总胆固醇比值的意义）]
Acta Univ Palacki Olomuc Fac Med. 1982;102:299-310.
引用本文的文献
1
Effects of pindolol and metoprolol on plasma lipids and lipoproteins.吲哚洛尔和美托洛尔对血脂及脂蛋白的影响。
Br J Clin Pharmacol. 1982;13(Suppl 2):435S-439S. doi: 10.1111/j.1365-2125.1982.tb01953.x.
2
Increased platelet adhesion and aggregation in hypertensive patients: effect of atenolol.高血压患者血小板黏附和聚集增加：阿替洛尔的作用。
Br J Clin Pharmacol. 1983 Dec;16(6):663-8. doi: 10.1111/j.1365-2125.1983.tb02238.x.
3
[Antihypertensive therapy and lipid metabolism].[抗高血压治疗与脂质代谢]
Klin Wochenschr. 1984 Mar 1;62(5):193-202. doi: 10.1007/BF01721044.
4
Thiazides, beta blockers and lipoproteins.噻嗪类利尿剂、β受体阻滞剂与脂蛋白
Postgrad Med J. 1983 Aug;59(694):483-8. doi: 10.1136/pgmj.59.694.483.
5
HDL cholesterol and beta-adrenoceptor blocking agents in a 5 year multifactorial primary prevention trial.在一项为期5年的多因素一级预防试验中的高密度脂蛋白胆固醇与β-肾上腺素能受体阻滞剂
Br J Clin Pharmacol. 1982;13(Suppl 2):431S-434S. doi: 10.1111/j.1365-2125.1982.tb01952.x.
6
The effects of antihypertensive drugs on serum lipids and lipoproteins. II. Non-diuretic drugs.抗高血压药物对血脂和脂蛋白的影响。II. 非利尿药物。
Drugs. 1986 Oct;32(4):335-57. doi: 10.2165/00003495-198632040-00003.
7
The effects of diuretics and adrenergic-blocking agents on plasma lipids.利尿剂和肾上腺素能阻滞剂对血浆脂质的影响。
West J Med. 1986 Aug;145(2):210-8.
8
Metabolic effects of carteolol and dilevalol in essential hypertension.
Eur J Clin Pharmacol. 1992;42(1):117-8. doi: 10.1007/BF00314932.
Zotero 插件